Reply to letter to the editor: Fracture-centered interpretation of antiresorptive therapy in men with prostate cancer receiving androgen deprivation therapy [0.03%]
致编辑信件的回复：雄激素剥夺治疗前列腺癌男性患者抗吸收疗法骨折中心解释法
Aya Bassatne,Ghada El-Hajj Fuleihan,Marlene Chakhtoura
Aya Bassatne
The "harlequin secret" of brown adipose tissue revisited: STAU1 as a post-transcriptional brake on adipose thermogenesis [0.03%]
“杂色隐秘”重新审视：STAU1作为脂肪产热的转录后制动因素
Antonio Giordano,Enzo Nisoli,Saverio Cinti
Antonio Giordano
Reduction of PDZK1 promotes diabetic kidney disease by modulating fatty acid uptake in proximal tubular epithelial cells [0.03%]
PDZK1减少通过调节近端小管上皮细胞中的脂肪酸摄取促进糖尿病肾病
Longyan Yang,Yan Wang,Di Wang et al.
Longyan Yang et al.
Introduction: Renal tubular injury drives the progression of diabetic kidney disease (DKD) and represents a promising therapeutic target. PDZK1, a scaffolding protein highly expressed in proximal tubules, regulates tubula...
The association of MASLD, lipoprotein(a) and long-term outcomes: Results from the multi-ethnic study of atherosclerosis [0.03%]
非酒精性脂肪肝病、脂蛋白(a)与长期预后之间的关系——动脉粥样硬化多民族研究的结果
Gomathy Nageswaran,Vignesh Chidambaram,Amudha Kumar et al.
Gomathy Nageswaran et al.
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of cardiovascular events and frequently coexists with other atherosclerosis risk factors, includin...
From metabolic subtypes to preventive decisions in high-risk type 2 diabetes [0.03%]
从2型糖尿病高危代谢亚型向预防决策的转化
Yanrong Chen,Yindi Zhang,Fadong Yu et al.
Yanrong Chen et al.
Diet and breast cancer: New perspectives on nutrition, metabolism, and immunity [0.03%]
饮食与乳腺癌：营养、代谢和免疫的最新观点
Ru Li,Xuemei Jiang,Yi Lu et al.
Ru Li et al.
Breast cancer is one of the most common malignant tumors among women worldwide. Despite the continuous development of various treatment strategies, including surgery, chemotherapy, endocrine therapy, targeted therapy, and immunotherapy, tum...
Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: Genetic evidence from large-scale phenomic analyses [0.03%]
基于大规模表型分析的遗传证据：GLP-1较高和GIP较低对体重和心血管代谢互补的好处
Lijuan Wang,Fangyuan Jiang,Shuai Yuan et al.
Lijuan Wang et al.
Background: The long-term health effects of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) remain unclear. Most importantly, it is highly controversial whether GIP agonists vs. anta...
Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023 [0.03%]
2050年动脉粥样硬化性心血管-肾脏-肝脏-代谢疾病负担的全球和区域预测：2023年全球疾病负担研究的预测分析
Jayanth Jayabaskaran,Srinithy Nagarajan,Haryo Raden Himan et al.
Jayanth Jayabaskaran et al.
Background: Cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), metabolic dysfunction-associated steatotic liver disease (MASLD), and obesity coexist under the cardiovascular-kidne...
Metabolic control of renal cell fate in kidney disease: nutrient rewiring, senescence and fibrosis [0.03%]
肾脏疾病中的肾细胞命运代谢调控：营养物质重组、衰老和纤维化
Hongtu Hu,Rui Ji,Jijia Hu
Hongtu Hu
The kidney is a metabolically demanding organ in which epithelial, endothelial, stromal and immune compartments operate within spatially specialized nutrient and oxygen microenvironments. Renal metabolic remodeling is not uniformly harmful:...